Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Pharmacyclics Switzerland Gmbh, explained in plain language.
This study offers continued access to ibrutinib for people with certain blood cancers or graft-versus-host disease who completed earlier ibrutinib trials and are still benefiting from the drug but cannot get it commercially. About 297 participants will receive ibrutinib while res…
Phase: PHASE4 • Sponsor: Pharmacyclics Switzerland GmbH • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC